key: cord-0824038-zhl2m2j2
authors: Young, Steven; Pollard, Richard J.; Shapiro, Fred E.
title: Pushing the envelope: New Patients, Procedures, and PPE in the Ambulatory Surgical Center for the COVID-19 Era
date: 2021-07-27
journal: Adv Anesth
DOI: 10.1016/j.aan.2021.07.006
sha: 0b9d102ce6e128df853cb260373569a1db77bac3
doc_id: 824038
cord_uid: zhl2m2j2

In 2018, over 23 million ambulatory surgeries were performed in the US, representing the continued trajectory of procedures moving from hospitals towards ambulatory facilities. The primary incentives are improved costs, convenience, and patient satisfaction. Careful evaluation of patients, procedures, costs, and outcomes is required to be successful. Due to the COVID-19 pandemic, surgeons and anesthesiologists must now pay attention to local, state, and federal guidelines developed to manage COVID-19: screening, testing, and PPE. A few positives have resulted from COVID-19: improved and more consistent facility hygiene, consistent mask usage, and social distancing. The rise of telemedicine in pre-anesthesia screening has facilitated Case flow, reducing same-day surgery cancellations while saving the everyone time and money.

Patients with OSA are at high risk of intraoperative complications such as difficult intubation and postoperative complications like hypoxia or unplanned hospital admission 10 . They may have accompanying comorbidities like HTN, DM, coronary artery disease, pulmonary hypertension, or heart failure, which may not necessarily be optimized. All patients should be screened for OSA with a validated screening tool, like the STOP-BANG questionnaire 12 . If they screen positive, they may benefit from a formal diagnosis and/or treatment of OSA and optimization of their comorbidities prior to a procedure. However, delaying surgery to diagnose and treat OSA may not necessarily improve perioperative outcomes 13 . Procedures should only occur in this population when the OSA has been managed with continuous positive airway pressure (CPAP) devices, or if they screen positive and have other comorbidities that are optimized 14 . These patients may benefit from narcotic-sparing anesthetic techniques, including regional anesthesia.

Guidelines for performing anesthesia for patients with MH in the outpatient setting have been updated recently by the ASA and Society for Ambulatory Anesthesia (SAMBA) and the North American MH Registry of the MH Association of the United States (MHAUS) 15, 16 . MH-susceptible patients can safely undergo procedures if their risk is appropriately identified, treatment for MH is available, or non-triggering anesthetics are used in the sedating or anesthetizing locations. Specific facilities classified as Class B, where sedation is via oral or intravenous sedative-hypnotics and/or analgesics, routinely do not stock dantrolene to treat MH because of the lack of MH-triggering agents. However, the ASA and SAMBA in a recent consensus statement suggest having succinylcholine available to treat laryngospasm for emergency airway rescue 17 .

When performing surgeries or procedures, emergencies (medical and non-medical) may occur.

In the hospital, many resources are available (e.g., equipment, drug, personnel, and intensive care unit). In the outpatient setting, these resources might not be as readily available, but these patients are generally healthier, and hence emergencies tend to be less frequent. However, if the patient has comorbidities that may place them at higher risk of perioperative complications, they may require a higher level of care and additional personnel. Having plans to deal with these patients and emergencies, such as using a cognitive aid (emergency manual) and/or having a standardized protocol for transfer to a higher-level facility, is essential 18, 19 . Facilities must establish policies, have a communication plan, and ongoing education programs to ensure staff are aware of the latest emergency protocols and qualified to handle emergencies.

During the past year, the selection of patients for ambulatory surgery has added challenges due to the appearance of Coronavirus Disease-19 (COVID-19). During the recent pandemic, surgeries continued, and literature about the effects of COVID-19 on the patient undergoing surgery was published. These data will help inform our understanding of the need to carefully select patients for outpatient procedures and how the unique pathophysiology and transmission pattern of the Sars-2-Coronavirus impacts surgical outcomes.

The procedures performed in ASCs have continued to change throughout the years. A combination of patient and surgeon desires and an improvement in the surgical equipment and techniques led this shift. Wider acceptance of enhanced recovery after surgery (ERAS) techniques has contributed to an explosion of cases performed in an ambulatory setting. With J o u r n a l P r e -p r o o f the continued advancement and complexity of patients and procedures, the challenge remains for the ASC to determine which patients and procedures can or should be done in their facility.

Orthopedic cases performed in ambulatory settings have traditionally been relatively minor procedures. With the advances in surgical and regional anesthetic techniques, more complex hospital procedures can now be performed in an outpatient setting. One type of high-cost surgical procedure that has been performed in hospital outpatient departments (HOPDs) for several years to commercially insured patients is total joint replacement. As the population ages, there has been a concurrent rise in surgeries for both total knee arthroplasty (TKA) and total hip arthroplasty (THA) in the United States, and recently, ASCs have begun offering these services 20 . In 2017, more than 200 ASCs were providing outpatient joint replacements; more than 25-50% of all joint replacements could be done in an outpatient facility with proper patient selection 21 .

In 2020, the Centers for Medicare and Medicaid Services (CMS) revoked the inpatient-only listing on approximately 300 primarily musculoskeletal-related services 22 . CMS's new policy indicates that procedures will migrate to outpatient facilities to the detriment of hospital-based practices. Outpatient facilities may be able to provide a similar level of care without a rise in complications. A matched cohort study demonstrated that with one-compartment knee arthroplasties, there was no statistically significant difference in complication rates between hospitals and ASCs or increased hospital admissions after the procedure 23 . Additionally, payment disparity between HOPDs and ASCs ($11,139 vs $18,595) may further drive orthopedic J o u r n a l P r e -p r o o f surgeries to ASCs 24 . Thus, the key decision that ASCs will have to make remain that of patient selection.

In 2019, an estimated 75 million endoscopies were performed in the United States, of which 51.5 million (68%) were gastrointestinal endoscopies 25 . Endoscopic services are primarily delivered in an outpatient setting. The ability to offer a diverse range of endoscopic and specialized services positions the ASC to take advantage of the well-reimbursed medical model in the United States. The ASC will also be able to provide diagnostic testing, such as laboratory, pathology, and imaging services which may enhance the revenue potential. Nonetheless, the facility should maintain a careful selection process for appropriate patients to be performed in these outpatient facilities. Poor patient or procedure selection can result in unwanted admission to an affiliated hospital 26, 27 .

The American Society of Plastic Surgery reported in 2019 that plastic surgeons performed more than 27.1 million cosmetic and reconstructive procedures in the United States. Of these, nearly 9 million occurred in ambulatory surgery centers 28 . There is a consistent uptrend over the past decade, representing 25% of reconstructive and 40% of the total cosmetic surgical procedures.

Some of this change can be attributed to intense scrutiny of complications due to office-based surgery, while some can be attributed to the advances in minimally invasive cosmetic and reconstructive surgical techniques 29, 30 . However, the authors maintain that cost, convenience, scheduling and privacy should also be considered as a strong motivator for this change. Patients who underwent office-based procedures were more likely to undergo single operations vs. combined operations. The continued evolution of the ASC to a place where rapid-onset and rapid-emergence anesthesia in a safe and highly comfortable environment will continue to fuel this move.

The rising shift to outpatient neurosurgical procedures has been partially due to better surgical techniques and increasing procedural safety 32, 33 . Minimally invasive techniques and careful patient selection have allowed neurosurgical procedures to be moved from hospitals to the ambulatory setting. It has been postulated that surgeons desire to minimize healthcare-related costs due to improved perioperative efficiency and cost reduction 34 . In 1996, the transition of cervical micro-discectomies from hospital-based settings to that of the ASC saved the healthcare industry approximately $140 million 35 . Factoring in the potential reductions in nosocomial infections and their associated costs, outpatient surgery's potential efficiency could be even greater 36 . Neurosurgeons initially performed single-level anterior cervical discectomy and fusions (ACDFs), but the range of cases has expanded to include posterior cervical foraminotomy, cervical arthroplasty, lumbar laminectomies and discectomies, and lumbar fusions 37 . Numerous studies have demonstrated that the complication rates, hospital transfer rates, and readmission rates for outpatient lumbar decompression surgeries are equivalent to, J o u r n a l P r e -p r o o f if not superior to, that of inpatient ones. Though the patient population needs careful selection to ensure the best outcomes, one study noted that patient satisfaction is increased in ASCs 38 .

Thoracic surgery would not ordinarily be considered as a possible candidate for inclusion in ambulatory surgery clinics. However, as ERAS techniques continue to improve and be implemented, this patient population might merit re-evaluation. Advances in video-assisted thoracic surgery have demonstrated that ambulatory procedures may be safely performed for mediastinal lymphadenectomy, lung biopsy, and thoracic sympathectomy 39, 40 . Studies have demonstrated that a tiny number of these patients require hospital admission postprocedurally. Anesthetic management for these procedures should focus on using ERAS guidelines, emphasizing rapid recovery and minimizing opioids.

The possibility of admittance to a hospital for management of postoperative complications such as the placement of a chest tube might continue to limit the inclusion of this specialty in most ASCs. However, the decreased length of stay from using ERAS techniques will likely lead to cost savings and thus, may be a consideration for some surgeons and anesthesiologists 41 .

Gynecologic procedures have always formed a significant percentage of cases performed in ASCs. With the development of surgical procedures of relatively short duration and suitable for discharge with minimal morbidity or mortality, the pool of possible cases will increase. SARS-CoV-2 can spread via small aerosols and larger droplets, via coughing, sneezing, speaking, or procedurally 49 . In particular, the concentration of infectious particles is highest in the short distance surrounding the patient vector. There is an incubation period of 4-5 days, during which the patient may be asymptomatic or pre-symptomatic. In particular, patients may be contagious 1-3 days before any symptom onset. Symptoms include may fever, cough, myalgias, anosmia, diarrhea, malaise 50 . Long-term outcomes and complications of COVID-19 remain under investigation and observation 51 . Some of these sequelae include cardiomyopathy and heart failure, persistent decreased pulmonary function, and neuropsychiatric symptoms like brain fog and seizures. Surgeons and proceduralists must now consider the critical role of COVID-19 infection: screening, testing, possible infectious spread, impact on patient outcomes, and personal protective equipment (PPE).

Multiple studies examined the association of COVID-19 infections in patients and postoperative 54 . Among patients with a COVID-19 diagnosis and pulmonary complications undergoing either emergency or elective surgery, there was a higher mortality rate at 30-days, accounting for 219 (81.7%) deaths, total deaths 268. In adjusted analyses, patients with COVID-19 were more likely to die at 30-days if they were age 70 or greater, male, had an ASA grade 3 to 5, undergo emergency surgery, and undergo major surgery.

The literature published so far points towards relatively higher morbidity and mortality among patients with a COVID-19 diagnosis, especially amongst those with pulmonary complications.

Several studies have documented infection with SARS-CoV-2 in patients who never have had symptoms (asymptomatic) and in patients not yet symptomatic (pre-symptomatic) 56 Ideally, we recommend that these mildly symptomatic patients have their surgery or procedure delayed for at least ten days after their symptom onset or after their last fever 59 . If the patient has had a severe COVID-19 illness or are immunocompromised, the timing should be increased to at least 20 days. After the quarantine period, providers should be aware that there may be residual viral shedding beyond those days, and therefore it would not be helpful to re-test an asymptomatic patient within 90 days. If there is a possibility of the patient becoming symptomatic and other infectious etiologies are ruled out, then re-testing for SARS-CoV-2 would be warranted. If their COVID-19 test is negative after adequate isolation, consider doing the elective procedure while maintaining proper PPE (PPE section).

Ambulatory surgery centers are accustomed to performing elective surgeries in patients who have suffered a recent major medical event, such as myocardial infarction or stroke. These patients should not have elective surgery or procedure until after eight weeks or three months, J o u r n a l P r e -p r o o f respectively. Similarly, in the case of symptomatic COVID-19, the authors recommend that patients ideally should wait a minimum of 8 weeks before elective surgery or procedure 60 .

Several COVID-19 vaccines have received emergency use approval by the Food and Drug Administration (FDA) 61-63 . These vaccines have been shown to be effective in preventing serious complications, hospitalizations, and death from COVID-19. They have also been shown to be well tolerated, with rare but serious allergic reactions noted 64 . However, the long-term data on the vaccines' ability to prevent patients from contracting COVID-19 or spreading COVID-19 are still underway.

Since the vaccine was approved under an emergency use authorization (EUA), it may not be feasible to mandate that all healthcare workers be immunized to work in a facility. Additionally, there is lack of data on transmission of COVID-19 by a vaccinated person to another individual.

For this reason, all vaccinated patients should still undergo COVID-19 testing before surgery, and all vaccinated healthcare workers should make efforts to ensure they are not exposed to COVID-19 infected individuals. These infectious disease guidelines will evolve as new data emerge regarding the transmissibility of COVID-19 in patients who have received the vaccine and the duration of their immunity. The CDC recommends using additional infection prevention and control practices during the COVID-19 pandemic, along with standard practices recommended as a part of routine healthcare delivery to all patients. Facilities should develop policies and procedures to ensure recommendations are appropriately applied.

The CDC has published recommendations on the use of PPE for healthcare facilities, which is being updated as data are produced regarding their efficacy 65 . Preventing spread involves source-control (preventing others' exposure) measures: using a well-fitting mask to prevent the spread of respiratory secretions and infectious particles when individuals are breathing, talking, sneezing, or coughing. Ensuring a proper fit via multiple modification methods optimizes both source control and infection prevention 66, 67 . Because of the potential for asymptomatic and pre-symptomatic transmission, source control measures are recommended for everyone in a healthcare facility, even if they do not have symptoms of COVID-19. All patients should be masked unless undergoing a procedure that requires access to the airway while in the health care facility. Facemasks that conform well to cover people's mouth and nose so that air preferentially moves through the material rather than through gaps at the edges are more effective for source control by decreasing particles emitted from the wearer and to which the wearer is exposed 67 [70] [71] [72] [73] [74] . The authors hypothesize that in the future, telemedicine may be further integrated into patient care with pre-anesthetic evaluations to facilitate the exponential growth of ambulatory procedures.

The potential for healthcare providers to be exposed to COVID-19 is not limited to direct patient contact. Transmission can also occur through fomites: unprotected exposures to asymptomatic or pre-symptomatic co-workers in breakrooms, hospital rooms, or other common areas 75 . Ideally, there should be designated areas with protected areas and staggered rest schedules to allow healthcare staff to take breaks and eat while allowing at least 6 feet of social distancing. All healthcare employees should wear well-fitted masks in healthcare facilities; these masks should only be removed after performing CDC recommended hand hygiene guidelines for eating and drinking, at the end of the shift, and for replacing with a clean mask prior to leaving the facility.

In addition to appropriate source control protocols for patients, ASCs should ensure that appropriate PPE is provided to the healthcare providers. Appropriate PPE may include NIOSHapproved N95 respirators, gowns, and face shields for procedures that generate aerosols. The Going forward, as more of the population become infected with and recover from COVID-19, it will be essential to build a framework and approach to treating these previously COVID-19 positive patients 60 . Many of them may have had to delay surgeries because hospitals had canceled elective procedures or because the patient had COVID-19, whether symptomatic or not.

In 2018, over 23 million ambulatory surgeries were performed in the US. The trajectory of procedural growth moving from the hospital setting towards ambulatory facilities will likely continue. The primary incentives cited for this change are improved costs, convenience, scheduling, privacy, and patient satisfaction.

The authors anticipate that there will be a continued increase in the number of innovative procedures performed within the ambulatory sphere. These will include procedures such as hysteroscopies, joint replacements, spine surgeries, advanced endoscopies, ophthalmologic procedures, and interventional radiologic, cardiac, vascular, and pain procedures. The onus will be placed upon ASCs to carefully evaluate these patients, procedures, costs, and outcomes to determine their facilities' risk/benefit ratio.

Patients with pre-existing comorbidities must continue to be optimized before their surgery or procedure. However, with the COVID-19 pandemic, surgeons, proceduralists, and anesthesiologists must now pay attention to protocols developed to cope with COVID-19: screening, testing, and PPE 69 . Ambulatory surgery centers and office-based practices should consider local, state, and federal regulations and specialty-specific guidelines about COVID-19. 

Ambulatory Surgery Data From Hospitals and Ambulatory Surgery Centers: United States

Trends Affecting Hospitals and Health Systems

Trends in Use of Ambulatory Surgery Centers for Cataract Surgery in the United States

Trends in Inpatient and Outpatient Hysterectomy and Oophorectomy Rates Among Commercially Insured Women in the United States

Growth of Nonoperating Room Anesthesia Care in the United States

Office-based anesthesia: Safety and outcomes

Office-based surgery and patient outcomes

Safety in office-based anesthesia: An updated review of the literature from

Office-based anesthesia: An update on safety and outcomes

STOP questionnaire: A tool to screen patients for obstructive sleep apnea

Obesity and Obstructive Sleep Apnea in the Ambulatory Patient

Diagnosis and Treatment of Obstructive Sleep Apnea in Adults

Malignant Hyperthermia-Susceptible Adult Patient and Ambulatory Surgery Center: Society for Ambulatory Anesthesia and Ambulatory Surgical Care Committee of the American Society of Anesthesiologists Position Statement

Succinylcholine use and dantrolene availability for malignant hyperthermia treatment: Database analyses and systematic review

Succinylcholine for emergency airway rescue in class b ambulatory facilities: The society for ambulatory anesthesia position statement

Hospitals may lose total joint replacements to ambulatory providers. Here's what they're doing about it

CY 2021 Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System Final Rule (CMS-1736-FC)

Safety and Cost-Effectiveness of Outpatient Unicompartmental Knee Arthroplasty in the Ambulatory Surgery Center

Payments for outpatient joint replacement surgery: A comparison of hospital outpatient departments and ambulatory surgery centers

Beckers Healthcare. 5 Trends Affecting the Gastroenterology Specialty

Complications of Anesthesia Services in Gastrointestinal Endoscopic Procedures

The Incidence and Cost of Unexpected Hospital Use After Scheduled Outpatient Endoscopy

Office Surgery Incidents: What Seven Years of Florida Data Show Us

Determining the Safety of Office-Based Surgery: What 10 Years of Florida Data and 6 Years of Alabama Data Reveal

Is Office-Based Surgery Safe? Comparing Outcomes of 183,914 Aesthetic Surgical Procedures Across Different Types of Accredited Facilities

Trend of Spine Surgeries in the Outpatient Hospital Setting Versus Ambulatory Surgical Center

National Trends in Ambulatory Surgery for Intervertebral

Disc Disorders and Spinal Stenosis. Spine (Phila Pa 1976)

Identifying the most appropriate lumbar decompression patients for ambulatory surgery centers -A pilot study using inpatient and outpatient hospital data

Day surgery for cervical microdiscectomy: is it safe and effective?

Anterior cervical discectomy and fusion in the outpatient ambulatory surgery setting compared with the inpatient hospital setting: analysis of 1000 consecutive cases

Spine Surgery in the Ambulatory Surgery Center Setting: Value-Based Advancement or Safety Liability? Neurosurgery

Patient satisfaction with outpatient lumbar microsurgical discectomy: a qualitative study

Outpatient video-J o u r n a l P r e -p r o o f mediastinoscopy

Improvements in thoracic surgery outcomes: a multiinstitutional collaboration study

Enhanced recovery after surgery for hip and knee arthroplasty: a systematic review and meta-analysis

Nationwide trends in the utilization of and payments for hysterectomy in the United States among commercially insured women

Movement to outpatient hysterectomy for benign indications in the United States

Patient satisfaction with outpatient hysteroscopy versus day case hysteroscopy: randomised controlled trial

High-risk surgical procedures and semi-emergent surgical procedures for ambulatory surgery

Decline of Pediatric Ambulatory Surgery Cases Performed at Florida General Hospitals Between

Mild or Moderate Covid-19. Solomon CG

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)

Long-term Health Consequences of COVID-19

The effects of COVID-19 on perioperative morbidity and mortality in patients with hip fractures

Impact of COVID-19 on clinical outcomes for patients with fractured hip

Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study

Perioperative Morbidity and Mortality of Patients With COVID-19 Who Undergo Urgent and Emergent Surgical Procedures

SARS-CoV-2 Infection in Children

Presymptomatic Transmission of SARS-CoV-2 -Singapore

Presumed Asymptomatic Carrier Transmission of COVID-19

Interim Guidance on Duration of Isolation and Precautions for Adults with COVID-19

Preparing previously COVID-19-positive patients for elective surgery: a framework for preoperative evaluation

Pfizer-BioNTech COVID-19 Vaccine

US Food and Drug Administration. Moderna COVID-19 Vaccine

US Food and Drug Administration

Maintaining Safety with SARS-CoV-2 Vaccines. Longo DL

Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic

Improve the Fit and Filtration of Your Mask to Reduce the Spread of COVID-19

Evaluation of Cloth Masks and Modified Procedure Masks as Personal Protective Equipment for the Public During the COVID-19

Performance of N95 Respirators: Filtration Efficiency for Airborne Microbial and Inert Particles

Patients, procedures, and PPE: Safe officebased anesthesia recommendations in the COVID-19 era

Reducing Surgery Cancellations at a Pediatric Ambulatory Surgery Center

Cancellation of pediatric outpatient surgery: Economic and emotional implications for patients and their families

The Virtual Pediatric Perioperative Home, Experience at a Major Metropolitan Safety Net Hospital. Pediatr Anesth

Role of Telehealth in Pre-anesthetic Evaluations

Improved satisfaction of preoperative patients after group video-teaching during interview at preanesthetic evaluation clinic: the experience of a medical center in Taiwan

Air and Environmental Contamination Caused by COVID-19 Patients: a Multi-Center Study

Using Personal Protective Equipment (PPE)

The Consequences of Delaying Elective Surgery: Surgical Perspective

Changes in Health Services Use Among Commercially Insured US Populations During the COVID-19 Pandemic